Espey Manufacturing & Electronics Corp. reported record annual revenue and gross profit as stronger margins helped fiscal 2026 net income surge 37% to $11.2 million, while a $134.9 million order backlog provides substantial visibility heading into the new fiscal year. Annual sales increased 5% to $46.1 million from $44 million, but net income grew considerably faster and diluted earnings reached $3.89 per share compared with $3.02 a year earlier. Fourth-quarter revenue accelerated 40% to $13.5 million and quarterly diluted EPS reached $1.15, beating the approximately $0.96 expected by analysts even though sales came in below the roughly $14.8 million consensus estimate. Shares fell roughly 5% following the release as investors weighed the earnings beat and strong backlog against the revenue miss and slower order intake during fiscal 2026.
The results show how dramatically Espey’s profitability has improved even without rapid top-line growth. Gross profit increased to $16.3 million from $12.7 million, pushing gross margin to approximately 35.3% from 28.9%, while the company remained debt-free and finished the year with nearly $45.4 million of combined cash and investment securities. Management expects fiscal 2027 revenue to exceed fiscal 2026 levels and says identified opportunities now total approximately $173 million, although converting that pipeline into orders will depend on defense procurement schedules, engineering execution and government funding.
Higher margins turn modest revenue growth into a much larger increase in Espey earnings
Espey’s fiscal 2026 sales increased by approximately $2.2 million, but gross profit rose by roughly $3.6 million. That combination lifted gross margin by more than six percentage points and allowed profit growth to substantially outpace revenue expansion.
Net income reached $11.18 million compared with $8.14 million during the prior year, while diluted EPS increased 28.8% to $3.89. The improvement suggests Espey benefited not only from higher shipment volumes but also from a more favorable mix of programs and stronger execution across engineering and manufacturing work.
Fourth-quarter performance accelerated the trend. Revenue climbed to $13.47 million from $9.60 million a year earlier, representing growth of approximately 40%, while quarterly net income increased to $3.34 million from $2.93 million and diluted EPS improved to $1.15 from $1.05.
The EPS result exceeded the single-analyst consensus estimate by $0.19, but revenue missed expectations by approximately $1.33 million. That split helps explain why investors did not reward the report despite the strong annual profit growth, because expectations had already risen alongside the stock and the company’s large backlog.
Espey is a small defense and industrial electronics manufacturer specializing in power supplies, transformers and related electronic equipment. Much of its business comes from prime defense contractors, the United States Department of Defense, other government agencies and foreign governments, making program timing and procurement cycles especially important to quarterly revenue.
That customer base can create uneven results because large programs often involve engineering and qualification work before entering production. A delayed approval or component shortage may shift revenue from one quarter into another even when the underlying contract remains intact, making backlog conversion a more useful long-term indicator than individual quarterly sales fluctuations.
$134.9 million backlog provides years of visibility despite slower fiscal 2026 order intake
Espey ended fiscal 2026 with approximately $134.9 million of backlog, only modestly below the $139.7 million reported a year earlier. The backlog is almost three times the company’s latest annual revenue, giving Espey a level of forward visibility unusual for a business with roughly $46 million of yearly sales.
Approximately $123.7 million of that backlog is funded, leaving about $11.2 million dependent on future funding. The unfunded component has declined substantially from roughly $33 million a year earlier, improving the quality of the backlog even though the total dollar amount decreased slightly.
Management expects roughly $48 million of the current backlog to ship during fiscal 2027. If achieved, that level alone would exceed fiscal 2026 sales before accounting for additional orders received and delivered during the year, supporting management’s expectation that revenue will increase.
Order intake was considerably weaker than the previous year, however. Espey received approximately $41.4 million of new orders during fiscal 2026 after receiving $86.4 million during fiscal 2025, when two unusually large multi-year awards totaling $49.4 million boosted bookings. Management expects fiscal 2027 new orders to meet or exceed the latest year’s total.
The comparison therefore needs context. Fiscal 2025 benefited from two major contracts that are not necessarily repeated every year, while the current backlog remains near record levels despite lower new orders.
Espey also reported approximately $173 million of identified opportunities as of early September, up from roughly $152.5 million in May. Management defines these opportunities as repeat or new programs it believes have a realistic chance of being awarded based on quotation status, expected award dates, historical ordering, defense-program funding and discussions with customers.
That pipeline is not equivalent to contracted backlog and should not be treated as guaranteed future sales. Still, the increase provides evidence that Espey continues bidding on a substantial pool of programs as defense customers modernize power electronics and related systems.
Defense concentration supports demand but creates contract and execution risks
Espey’s exposure to defense spending is central to its growth story. The company supplies equipment used in military and industrial applications where products can remain in production for years after initial qualification, creating long revenue tails once Espey secures a position on a major platform.
The same model creates customer concentration. During fiscal 2026, five customers individually represented between 11% and 16% of annual sales, while earlier filings showed three significant customers accounting for most of the company’s backlog.
Management argues that the concentration is less risky than it initially appears because a single customer can participate in several unrelated programs. Losing one contract therefore would not necessarily eliminate the entire customer relationship, although dependence on a relatively small number of large defense customers remains an important risk.
Engineering execution represents another constraint. Roughly $14.9 million of backlog relates to engineering programs, and management notes that technical complexity, staffing availability, customer approvals and long lead times for prototype materials can delay revenue recognition. Cost overruns can also reduce margins if engineering work takes longer than expected.
Management has warned that the fiscal 2027 sales mix is likely to shift toward newer products requiring heavier engineering investment. Revenue may therefore increase while gross-margin growth temporarily slows, making the exceptional fiscal 2026 margin expansion difficult to extrapolate directly into the next year.
Labor and supply-chain conditions also remain relevant. Espey has described its workforce as stable but continues to face longer hiring times for specialized positions, while shortages or delays involving components can push scheduled backlog shipments into later periods.
Cash-rich balance sheet supports dividends and investment without adding debt
Espey ended fiscal 2026 with approximately $19.4 million of cash and $26 million of investment securities, producing more than $45 million of combined liquidity-related assets. Working capital reached roughly $54.7 million, while the company reported no borrowings during either of the past two fiscal years.
The company maintains a $3 million credit facility that expires in March 2027 but has not needed to draw on it. That balance-sheet position gives Espey substantial flexibility relative to its roughly $180 million equity market value and reduces financial risk as it invests in additional engineering staff, equipment and production capacity.
Operating cash flow declined sharply to $5.7 million from approximately $21 million despite higher earnings. The difference was driven largely by working-capital requirements, including increased inventory, receivables and other operating assets, showing that accounting profitability did not translate into equivalent cash generation during the year.
Inventory tied to contracts in process increased materially as Espey prepared for future deliveries. That can be consistent with a large backlog, but it also ties up cash before customers receive completed products and emphasizes why investors should track operating cash flow alongside net income.
Espey continues returning some of its excess cash to shareholders. The company paid $1.75 per share of dividends during fiscal 2026, totaling approximately $4.8 million, and recently declared another $0.75 special dividend in addition to its regular $0.25 quarterly payment.
The recurring quarterly dividend is now $1 annually before special distributions. Espey’s willingness to pay additional dividends reflects its cash-rich balance sheet, although future special payments will depend on investment requirements, order growth and working-capital demands.
Espey shares fall as strong profit growth meets higher investor expectations
Espey entered the earnings report with its stock around $64.30 and a market capitalization close to $181 million. Shares had already appreciated significantly over the preceding year as investors responded to rising defense demand, improved profitability and the company’s expanding backlog.
The stock fell roughly 5% after the results, trading near $61 despite the EPS beat. The market reaction appears consistent with investors focusing on the revenue miss, the modest decline in backlog and slower order intake rather than the strong annual increase in net income.
Valuation has also become less forgiving following the share-price appreciation. Espey was recently trading at approximately 17 times expected earnings, compared with around 15 times three months earlier, while limited analyst coverage means relatively small changes in expectations can create larger stock moves.
The longer-term story nevertheless remains tied to backlog execution rather than a single quarterly miss. Approximately $48 million of expected backlog shipments could support another annual revenue record, while the $173 million opportunity pipeline provides the potential for additional multi-year orders.
The main issue for fiscal 2027 is whether Espey can convert that demand into higher revenue while protecting the margins that drove fiscal 2026 earnings growth. More engineering-intensive programs could pressure near-term profitability, but successful qualification could create recurring production revenue for several years afterward.
For a company of Espey’s size, even one or two large defense awards can materially change the backlog and earnings trajectory. That makes new-order activity, gross margin and backlog funding the most important indicators to monitor as the new fiscal year progresses.
Key takeaways from Espey’s record profit and $134.9 million defense electronics backlog
- Fiscal 2026 revenue increased 5% to a record $46.1 million, while net income surged 37% to $11.2 million.
- Diluted EPS increased to $3.89 from $3.02 as stronger margins allowed profit growth to substantially outpace revenue.
- Fourth-quarter revenue jumped about 40% to $13.5 million and EPS of $1.15 exceeded analyst expectations.
- Gross margin expanded to approximately 35.3% from 28.9%, providing the biggest driver of annual earnings growth.
- Backlog remained strong at $134.9 million, with approximately $123.7 million already funded.
- Management expects roughly $48 million of existing backlog to ship during fiscal 2027 and expects annual revenue to exceed fiscal 2026.
- New orders fell to about $41.4 million after unusually large fiscal 2025 contract awards, but management expects fiscal 2027 bookings to meet or exceed that level.
- Identified business opportunities have increased to approximately $173 million, although those opportunities are not contracted backlog.
- Espey holds more than $45 million of cash and investment securities and reported no borrowings during the past two fiscal years.
- Shares fell roughly 5% as investors weighed the EPS beat against a revenue miss, lower backlog and slower annual order intake.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.